(Q39788078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Tingyuan Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Xueqing Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jiancheng Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Xuan Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Qiang Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

Journal of Drug Targeting

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

254-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

Detection of sulfide release from the oxygen-sensing [4Fe-4S] cluster of FNR.

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Integrins: versatility, modulation, and signaling in cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Integrins, adhesion and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Tumour vascular targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Ligand-targeted liposomal anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Integrins and angiogenesis: a sticky business

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Stealth monensin immunoliposomes as potentiator of immunotoxins in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903353354

10.3109/10611860903353354

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19824864%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference